BMEA stock news · Biomea Fusion
Get alerts for BMEA
Follow Biomea Fusion (BMEA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BMEA12 health care stocks are changing a lot during Wednesday's trading.
NeutralBiomea Fusion's shares fell 33.27% on Wednesday. The story gives no company update, so the move alone does not change the view of its business.
12 health care stocks are changing a lot before the market opens on Wednesday.
NeutralBiomea Fusion shares fell about 21% before Wednesday's market opened. The article gives no company news behind the move, so it does not change the outlook.
State Street, Fastenal, and other major stocks dropped in early trading on Wednesday.
NeutralBiomea Fusion announced Phase 1 results for its weight-management drug, but the story gives no results details. It therefore does not show a clear change in the company's outlook.
12 health care stocks changed a lot in prices after the market closed on Tuesday.
NeutralBiomea Fusion shares fell about 24% after hours. The article gives no business reason for the move, so it does not change what we know about the company.
Biomea Fusion shares jumped 7% after regular trading ended: What’s happening?
NeutralBiomea Fusion scheduled a Tuesday, Oct. 13 call to discuss BMF-650 Phase I results. The report gives no findings, so it does not change what is known about the drug.
12 health care companies saw big changes in their stock prices after the market closed on Monday.
NeutralBiomea Fusion shares rose 11% in Monday's after-hours session, but the article gives no company news explaining the move. It does not change the company's outlook.
Biomea Fusion, Inc. shares news about when it expects results from its GLP-131 trial.
NeutralBiomea filed an 8-K updating when to expect Phase I topline results; the note only sets a date and does not change the company's outlook.